Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the NEURO-TTRansform Clinical Trial.
Journal: Journal of the peripheral nervous system : JPNS
Published: June 05, 2026
Polyneuropathy in p.V142I hereditary transthyretin amyloidosis: Diagnostic challenges and clinical considerations.
Journal: Journal of the neurological sciences
Published: May 19, 2026
Early-Onset Wild-Type Transthyretin Amyloidosis Polyneuropathy.
Journal: Muscle & nerve
Published: December 22, 2025
Prevalence and attribution of polyneuropathy in p.V142I (V122I) hereditary transthyretin amyloidosis.
Journal: Journal of the neurological sciences
Published: November 12, 2025
Best Practices and Key Barriers for Amyloidosis Patient Care at US Specialized Amyloidosis Centers: An Analysis by ARC-ASPIRE.
Journal: Clinical Medicine Insights. Cardiology
Published: October 07, 2025
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy: An Exploratory Analysis of Treatment Effect in Male and Female Patients.
Journal: Muscle & nerve
Published: August 07, 2025
Correction: Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform.
Journal: Journal of neurology
Published: February 03, 2025
Hereditary Transthyretin Amyloidosis in Patients Referred to a Genetic Testing Program.
Journal: Journal of the American Heart Association
Published: November 22, 2024
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells.
Journal: Nature biotechnology
Published: November 14, 2024
Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform.
Journal: Journal of neurology
Published: June 27, 2024
Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health-Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin Amyloidosis.
Journal: Muscle & nerve
Published: March 25, 2024
Last Updated: 09/26/2026